Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Iteos Therapeutics, Inc. (ITOS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 37,960,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 5,000 5,000
Total Buy Value $0 $0 $41,850 $41,850
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 350,000 379,615
Total Sell Value $0 $0 $5,692,673 $6,289,886
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 3
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 227
  Page 9 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mcgrath Yvonne VP, Research and Development   •       –      –    2021-05-17 4 AS $24.41 $195,719 D/D (7,926) 0     -
   Mcgrath Yvonne VP, Research and Development   •       –      –    2021-05-17 4 OE $4.23 $33,527 D/D 7,926 7,926     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-04-09 4 AS $29.99 $3,569 I/I (119) 3,665,787     -
   Mpm Oncology Impact Management Gp Llc 10% Owner   –       –       •   2021-04-09 4 AS $29.99 $5,998 I/I (200) 6,004,368     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-04-09 4 AS $29.99 $3,569 I/I (119) 3,665,787     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-04-08 4 AS $30.51 $589,089 I/I (19,304) 3,655,906     -
   Mpm Oncology Impact Management Gp Llc 10% Owner   –       –       •   2021-04-08 4 AS $30.51 $985,802 I/I (32,304) 6,004,568     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-04-08 4 AS $30.51 $589,089 I/I (19,304) 3,655,906     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-04-07 4 AS $0.00 $0 I/I (15,670) 3,685,210     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-04-07 4 AS $32.07 $188,254 I/I (5,783) 3,700,880     -
   Mpm Oncology Impact Management Gp Llc 10% Owner   –       –       •   2021-04-07 4 AS $0.00 $0 I/I (15,670) 6,036,872     -
   Mpm Oncology Impact Management Gp Llc 10% Owner   –       –       •   2021-04-07 4 AS $32.07 $315,048 I/I (9,678) 6,052,542     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-04-07 4 AS $0.00 $0 I/I (15,670) 3,685,210     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-04-07 4 AS $32.07 $188,254 I/I (5,783) 3,700,880     -
   Oncology Impact Fund (cayman) Management L.p. X*   –       –      –    2020-07-28 4 B $19.00 $6,080,000 I/I 320,000 2,355,557 0.01     -
   Oncology Impact Fund (cayman) Management L.p. X*   –       –      –    2020-07-28 4 A $0.00 $0 I/I 5,742,220 2,195,557     -
   Davis Aaron I. Director   –       •       •   2020-07-28 4 B $19.00 $27,075,000 I/I 1,425,000 72,243 2.25     -
   Davis Aaron I. Director   –       •       •   2020-07-28 4 A $0.00 $0 I/I 2,992,259 48,691     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2020-07-28 4 B $19.00 $3,040,000 I/I 160,000 25,974 1.5     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2020-07-28 4 A $0.00 $0 I/I 3,546,663 24,853     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2020-07-28 4 B $19.00 $3,040,000 I/I 160,000 25,974 1.5     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2020-07-28 4 A $0.00 $0 I/I 3,546,663 24,853     -
   Mva Investors, Llc 10% Owner   –       –       •   2020-07-28 4 B $19.00 $27,075,000 D/D 1,425,000 72,243 2.45     -
   Mva Investors, Llc 10% Owner   –       –       •   2020-07-28 4 A $0.00 $0 D/D 2,992,259 48,691     -
   Shah Rajeev M. 10% Owner   –       –       •   2020-07-28 4 B $19.00 $27,075,000 I/I 1,425,000 4,417,259 1.5     -
  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us